Skip to the page

Data / Form D filings / Gnosko Bio Inc.

Gnosko Bio Inc.: Form D filing

Gnosko Bio Inc., a biotechnology company in Wayne, PA, filed a Form D with the SEC in 2024. The latest, on July 1, 2024, reports $100,000 sold of a $1.7 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
256 UPPER GULPH ROAD, Wayne, PA, 19087
Phone
(610) 715-3783
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2028853

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 1, 2024New notice$1,700,000$100,000$1,600,0002May 1, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sam AgrisExecutive Officer, Director
Danielle BradyExecutive Officer, Director
William WendelExecutive Officer, Director, Promoter
George CokenakesExecutive Officer, Director

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Jul 1, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Gnosko Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.